GPT and cancer: To identify potential drug vulnerabilities in cells using ALT mechanisms, we performed a comparative anti-cancer compound library screen on two immortalized cell lines, both derived from the same parental cell line (IMR90): SW26 (ALT-positive) and SW39 (telomerase-positive)20 (Fig. 1a).